NDC 59572-215

Thalomid

Thalidomide

Thalomid is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Celgene Corporation. The primary component is Thalidomide.

• Product ID: 59572-215_460c5af2-8633-42bc-a1ab-488ad82e440e
• NDC: 59572-215
• Product Type: Human Prescription Drug
• Proprietary Name: Thalomid
• Generic Name: Thalidomide
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2007-03-20
• Marketing Category: NDA / NDA
• Application Number: NDA020785
• Labeler Name: Celgene Corporation
• Substance Name: THALIDOMIDE
• Active Ingredient Strength: 150 mg/1
• Pharm Classes: Decreased Immunologically Active Molecule Activity [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 59572-215-93

4 BLISTER PACK in 1 BOX (59572-215-93) > 28 CAPSULE in 1 BLISTER PACK (59572-215-13)

• Marketing Start Date: 2007-03-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 59572-215-93 [59572021593]

Thalomid CAPSULE

• Marketing Category: NDA
• Application Number: NDA020785
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2007-03-20

NDC 59572-215-13 [59572021513]

Thalomid CAPSULE

• Marketing Category: NDA
• Application Number: NDA020785
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2007-03-20

Drug Details

Active Ingredients

Ingredient	Strength
THALIDOMIDE	150 mg/1

OpenFDA Data

• SPL SET ID: 2eda833b-1357-4ed4-a093-194524fcb061
• Manufacturer:
  • Celgene Corporation
• UNII:
  • 4Z8R6ORS6L
• RxNorm Concept Unique ID - RxCUI:
  • 200390
  • 213360
  • 700418
  • 700416
  • 404449
  • 404450
  • 360177
  • 360176

Pharmacological Class

• Decreased Immunologically Active Molecule Activity [PE]

NDC Crossover Matching brand name "Thalomid" or generic name "Thalidomide"

NDC	Brand Name	Generic Name
59572-205	Thalomid	Thalidomide
59572-210	Thalomid	Thalidomide
59572-215	Thalomid	Thalidomide
59572-220	Thalomid	Thalidomide